Systemic steroid treatment for severe skin rash induced by imatinib in patients with gastrointestinal stromal tumor (GIST): A phase II study

MLA

W.J. Lee, et al. “Systemic Steroid Treatment for Severe Skin Rash Induced by Imatinib in Patients with Gastrointestinal Stromal Tumor (GIST): A Phase II Study.” Annals of Oncology, vol. 29, Oct. 2018, p. viii583. EBSCOhost, https://doi.org/10.1093/annonc/mdy299.018.

APA

W.J. Lee, Min-Hee Ryu, M.W. Lee, E.J. Kim, Sook Ryun Park, Mo Youl Beck, & Y-K. Kang. (2018). Systemic steroid treatment for severe skin rash induced by imatinib in patients with gastrointestinal stromal tumor (GIST): A phase II study. Annals of Oncology, 29, viii583. https://doi.org/10.1093/annonc/mdy299.018

Chicago

W.J. Lee, Min-Hee Ryu, M.W. Lee, E.J. Kim, Sook Ryun Park, Mo Youl Beck, and Y-K. Kang. 2018. “Systemic Steroid Treatment for Severe Skin Rash Induced by Imatinib in Patients with Gastrointestinal Stromal Tumor (GIST): A Phase II Study.” Annals of Oncology 29 (October): viii583. doi:10.1093/annonc/mdy299.018.